Senija Behrem is an author at University of Rijeka specializing in pathology, medicine, and tumor biology.
Top concepts
MedicinePathologyGliomaCell BiologyTumor BiologyNeuro-oncologyTumor MicroenvironmentGynecologyOsteoporosisPublic Health
Publications per year
2004–2008
4
4
Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Senija Behrem, Kamelija Žarković, Neven Eškinja et al. · PubMed · 2005 · 67 citations
Rows per page
1–4 of 4